Asemblis and Viscofan BioEngineering have entered a strategic partnership to advance the biofabrication of 3D tissue models for preclinical research and development.

Asemblis is a Swiss specialist company in next-generation biofabrication and additive manufacturing technologies. With its industry insights and know-how, the company will market Viscofan BioEngineering’s Fibercoll-Flex®, the only fibrillar collagen type-1 bioink on the market.

“We see this collaboration as a catalyst for innovation. Partnering with Asemblis will help us expand the reach of our collagen-based materials and accelerate the adoption of physiologically relevant 3D models across the industry.”
Dr. Jesús Izco, Diversification Manager at Viscofan BioEngineering